CSPG4 and central nervous system cancer: The relevance of these findings to glioma growth in vivo is emphasized by the reduced growth of NG2-knockdown U87 tumors compared to control NG2-positive U87 tumors, likely due to diminished cell proliferation in the knockdown tumors.